| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |